Viemed Healthcare Gelecekteki Büyüme
Future kriter kontrolleri 4/6
Viemed Healthcare is forecast to grow earnings and revenue by 32.5% and 11.8% per annum respectively while EPS is expected to grow by 24.6% per annum.
Anahtar bilgiler
32.5%
Kazanç büyüme oranı
24.6%
EPS büyüme oranı
| Healthcare kazanç büyümesi | 20.1% |
| Gelir büyüme oranı | 11.8% |
| Gelecekteki özkaynak getirisi | n/a |
| Analist kapsamı | Low |
| Son güncelleme | 09 Sep 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
When Should You Buy Viemed Healthcare, Inc. (NASDAQ:VMD)?
Apr 11
These 4 Measures Indicate That Viemed Healthcare (NASDAQ:VMD) Is Using Debt Safely
Mar 07Viemed Healthcare: Comments On Q2 Earnings
Aug 25Viemed Healthcare Q2 2022 Earnings Preview
Aug 02Viemed Healthcare: New Bullish Trend Has Just Begun
Dec 29Viemed Healthcare, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 06Viemed Healthcare EPS misses by $0.01, revenue in-line
May 03Strong Execution By Insider-Owners Ensures Viemed's Growth
Jan 11Viemed Healthcare EPS misses by $0.02, beats on revenue
Nov 05Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 12/31/2026 | 276 | 20 | N/A | 54 | 1 |
| 12/31/2025 | 249 | 15 | N/A | 45 | 3 |
| 12/31/2024 | 221 | 9 | N/A | 39 | 3 |
| 6/30/2024 | 206 | 9 | 8 | 38 | N/A |
| 3/31/2024 | 194 | 10 | 8 | 36 | N/A |
| 12/31/2023 | 183 | 10 | 19 | 45 | N/A |
| 9/30/2023 | 170 | 9 | 16 | 40 | N/A |
| 6/30/2023 | 156 | 7 | 11 | 34 | N/A |
| 3/31/2023 | 146 | 6 | 7 | 31 | N/A |
| 12/31/2022 | 139 | 6 | 5 | 28 | N/A |
| 9/30/2022 | 133 | 8 | 5 | 29 | N/A |
| 6/30/2022 | 127 | 9 | 0 | 26 | N/A |
| 3/31/2022 | 121 | 9 | 3 | 25 | N/A |
| 12/31/2021 | 117 | 9 | 3 | 22 | N/A |
| 9/30/2021 | 116 | 10 | 2 | 20 | N/A |
| 6/30/2021 | 120 | 11 | 10 | 22 | N/A |
| 3/31/2021 | 136 | 29 | 29 | 39 | N/A |
| 12/31/2020 | 131 | 32 | 22 | 35 | N/A |
| 9/30/2020 | 122 | 29 | 26 | 37 | N/A |
| 6/30/2020 | 108 | 29 | 24 | 35 | N/A |
| 3/31/2020 | 86 | 11 | 2 | 19 | N/A |
| 12/31/2019 | 80 | 9 | 6 | 19 | N/A |
| 9/30/2019 | 76 | 9 | 7 | 20 | N/A |
| 6/30/2019 | 73 | 8 | 8 | 19 | N/A |
| 3/31/2019 | 68 | 9 | 16 | 22 | N/A |
| 12/31/2018 | 64 | 10 | 16 | 22 | N/A |
| 9/30/2018 | 60 | 7 | 11 | 15 | N/A |
| 6/30/2018 | 56 | 9 | 10 | 13 | N/A |
| 3/31/2018 | 51 | 8 | N/A | 9 | N/A |
| 12/31/2017 | 47 | 8 | N/A | 12 | N/A |
| 9/30/2017 | 43 | 11 | N/A | 14 | N/A |
| 12/31/2016 | 31 | 1 | N/A | 6 | N/A |
| 12/31/2015 | 38 | 10 | N/A | 10 | N/A |
| 12/31/2014 | 23 | 9 | N/A | 8 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: VMD's forecast earnings growth (32.5% per year) is above the savings rate (2.5%).
Kazançlar ve Piyasa: VMD's earnings (32.5% per year) are forecast to grow faster than the US market (15.4% per year).
Yüksek Büyüme Kazançları: VMD's earnings are expected to grow significantly over the next 3 years.
Gelir ve Pazar: VMD's revenue (11.8% per year) is forecast to grow faster than the US market (8.9% per year).
Yüksek Büyüme Geliri: VMD's revenue (11.8% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if VMD's Return on Equity is forecast to be high in 3 years time